Skip to content
Screener

Celcuity CELC Total Liabilities

Total Liabilities at other companies

Gilead Sciences logo
Gilead SciencesGILD
$535M
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$3.64B+44.4%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$77.45M+22.6%
Immunome logo
ImmunomeIMNM
$31.11M-12.5%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
$21.21M-8.3%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$79.16M+43.5%

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.55B+150%
Enterprise value$4.54B+142%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The source filing: Celcuity’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 5:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001493152-26-023180
Line itemMarch 31, 2026December 31, 2025
Total current liabilities33,21144,152
Convertible notes195,566195,324
Note payable127,862126,527
Total liabilities356,639366,003
Commitments and contingencies (Note 6)--
Stockholders’ equity:
Preferred stock, $0.001 par value; 2,500,000 shares authorized as of March 31, 2026, and December 31, 2025; 0 shares issued and outstanding as of March 31, 2026, and December 31, 2025
Common stock, $0.001 par value; 95,000,000 shares authorized as of March 31, 2026, and December 31, 2025; 48,347,390 and 48,244,960 shares issued and outstanding as of March 31, 2026, and December 31, 2025, respectively4848

Item 1. Financial Statements (unaudited) ITEM

FAQ

What is Celcuity's total liabilities?
Celcuity (CELC) reported total liabilities of $356.64M in Q1 2026.
How has Celcuity's total liabilities changed year-over-year?
Celcuity's total liabilities increased by 171.3% year-over-year, from $131.46M to $356.64M.
What is the long-term trend for Celcuity's total liabilities?
Over 5 years (2020 to 2025), Celcuity's total liabilities has grown at a 211.2% compound annual growth rate (CAGR), from $1.25M to $366M.
What does total liabilities mean?
The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.

Ask your AI about Celcuity's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude